LRRK2 and Parkinson disease: For instance, we were able to detect centrosomal cohesion deficits in PBMC derived lymphoblastoid cell lines from LRRK2 G2019S Parkinson’s disease patients, as well as in a subset of sporadic PD patients (Fernandez et al., 2019).